About GE Healthcare Technologies, Inc. 
GE Healthcare Technologies, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 146 Schemes (43.88%)
Foreign Institutions
Held by 424 Foreign Institutions (18.32%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
5,698 Million
(Quarterly Results - Dec 2025)
Net Profit:
602 Million
Pharmaceuticals & Biotechnology
USD 32,891 Million (Mid Cap)
15.00
NA
0.10%
0.54
20.79%
3.17






